Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Triaxial fluctuations of the test arm are measured with a smartphone
Custom Funtion Formula for your brand
Long-term health outcomes of lecanemab in patients with early alzheimers disease using simulation modeling
In the pivotal SURMOUNT-1 trial involving adults without diabetes, participants receiving the highest dose (15 mg) lost an average of 20.9% of their body weight over 72 weeks, compared to 3.1% with placebo
Pick the one that gives you a clear, memorable number
Collectively, these strengths position this study as a significant contribution to the growing field of psychiatric genetics and therapeutic development
US$ 29.08
US$ 25.32
US$ 26.98
